Filtered By:
Specialty: Cardiology
Procedure: Coronary Artery Bypass Graft

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 758 results found since Jan 2013.

Coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction: Short- and long-term outcomes
CONCLUSION: Based on our findings, coronary artery bypass grafting can be performed in patients with ischemic heart disease and severe left ventricular systolic dysfunction with acceptable hospital morbidity and mortality and long-term survival.PMID:34144786 | DOI:10.1016/j.ancard.2021.05.006
Source: Annales de Cardiologie et d'Angeiologie - June 19, 2021 Category: Cardiology Authors: M Tribak M Konat é S Saidi L Mahfoudi A Elhassani L-H Leghlimi F Lachhab N Bendagha A Soufiani J Filal A Maghraoui A Bensouda L Marmade S Moughil Source Type: research

New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial
ConclusionsA well-calibrated risk-score identified patients at risk of new-onset AF in the COMMANDER-HF trial. Patients who developed AF had a higher risk of subsequent death.Graphic abstractRisk of new-onset atrial fibrillation in patients with HFrEF and coronary artery disease
Source: Clinical Research in Cardiology - June 14, 2021 Category: Cardiology Source Type: research

Internal Mammary Artery and Its Resilience to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs
Arterioscler Thromb Vasc Biol. 2021 Jun 10:ATVBAHA121316256. doi: 10.1161/ATVBAHA.121.316256. Online ahead of print.ABSTRACTFueled by the global surge in aging, atherosclerotic cardiovascular disease reached pandemic dimensions putting affected individuals at enhanced risk of myocardial infarction, stroke, and premature death. Atherosclerosis is a systemic disease driven by a wide spectrum of factors, including cholesterol, pressure, and disturbed flow. Although all arterial beds encounter a similar atherogenic milieu, the development of atheromatous lesions occurs discontinuously across the vascular system. Indeed, the in...
Source: Arteriosclerosis, Thrombosis and Vascular Biology - June 10, 2021 Category: Cardiology Authors: Simon Kraler Peter Libby Paul C Evans Alexander Akhmedov Martin O Schmiady Michael Reinehr Giovanni G Camici Thomas F L üscher Source Type: research

Prospective multicenter registry of hybrid coronary artery revascularization combined with non-saphenous vein graft surgical bypass and percutaneous coronary intervention using everolimus eluting metallic stents (PRIDE-METAL study)
This study aimed to investigate a 1-year clinical follow-up of a prospective multicenter registry of HCR combined with non-saphenous vein graft surgical bypass and PCI using everolimus-eluting metallic stents (the PRIDE-METAL study). From June 2016 to June 2018, a total of 54 patients with multivessel coronary disease from six Japanese institutes were enrolled in this study. The primary endpoint of the study was the occurrence of major adverse cardiovascular event (MACE; all-cause death, myocardial infarction, stroke, and repeat revascularization) at 1 year. Three patients declined before complete HCR, and two patients wer...
Source: Cardiovascular Intervention and Therapeutics - May 18, 2021 Category: Cardiology Source Type: research

Single-Dose del Nido Cardioplegia Compared With Standard Cardioplegia During Coronary Artery Bypass Grafting at a Veterans Affairs Hospital
Tex Heart Inst J. 2021 Jan 1;48(1):e196981. doi: 10.14503/THIJ-19-6981.ABSTRACTDel Nido cardioplegic solution (DNC), used chiefly in pediatric patients, rapidly induces prolonged cardiac arrest during cardiac surgery. To determine whether surgical outcomes after coronary artery bypass grafting in a United States military veteran population differed when DNC was used instead of our standard Plegisol cardioplegia, we retrospectively reviewed 155 consecutive operations performed from July 2016 through June 2017. Del Nido cardioplegia was used to induce cardiac arrest in 70 patients, and Plegisol in 85. Compared with the Plegi...
Source: Texas Heart Institute Journal - May 4, 2021 Category: Cardiology Authors: Michael R Reidy Ernesto Jimenez Shuab Omer Lorraine D Cornwell Sabrina X Runbeck Ourania Preventza Gabriel Loor Todd K Rosengart Joseph S Coselli Source Type: research